Erythromycin Lactobionate
- Product NDC
- 51754-7000
- 11-digit product format
- 517547000
- Labeler code
- 51754
- Product ID
- 51754-7000_e69b3024-f4bd-456e-8c74-2f9bc33739c9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ERYTHROMYCIN LACTOBIONATE
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Exela Pharma Sciences, LLC
- Application
- ANDA211086
- Marketing category
- ANDA
- Marketing start
- 2021-03-15
- Marketing end
- 0000-00-00
- Substance
- ERYTHROMYCIN LACTOBIONATE
- Active strength
- 500 mg/10mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51754-7000 | ERYTHROMYCIN LACTOBIONATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [EXELA PHARMA SCIENCES, LLC] | 1 | Legacy NDC | 20210316_e69b3024-f4bd-456e-8c74-2f9bc33739c9.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51754-7000-3 | 51754700003 | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (51754-7000-3) > 10 mL in 1 VIAL, SINGLE-DOSE | 2021-03-15 | 0000-00-00 | No | No | Current |